Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Law firm probes ADMA Biologics' leadership for possible breaches of fiduciary duty
ADMA
$9.37
+$0.03 +0.32%

Law firm probes ADMA Biologics' leadership for possible breaches of fiduciary duty

Market News
18 Aug 2026
Newsfile Corp
View Source
Bearish
pluang ai news

Bernstein Liebhard LLP is investigating whether certain directors and officers of ADMA Biologics, Inc. breached their fiduciary duties to the company and its shareholders. The investigation aims to determine if the leadership acted in shareholders' best interests and if legal action is warranted. Current ADMA shareholders who purchased shares before August 9, 2024, are encouraged to contact the firm for more information about their legal rights. This probe could lead to legal remedies depending on the findings from publicly available information.

More News (ADMA)

Investigation launched into ADMA Biologics for alleged revenue inflation via channel-stuffing.

Investigation launched into ADMA Biologics for alleged revenue inflation via channel-stuffing.

Berger Montague PC is investigating ADMA Biologics' Board of Directors for potential breaches of fiduciary duty related to alleged channel-stuffing practices. The firm suspects ADMA inflated revenue growth by pushing more of its flagship product, ASC...

Market News
Bearish
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App